Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest (Q39300912)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

apoptotic process

0 references

1 reference

based on heuristic

inferred from title

peritoneal carcinomatosis

1 reference

based on heuristic

inferred from title

Reingard Senekowitsch-Schmidtke

13

object named as

Reingard Senekowitsch-Schmidtke

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

2

object named as

Christof Seidl

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Frank Bruchertseifer

10

object named as

Frank Bruchertseifer

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Alfred Morgenstern

11

object named as

Alfred Morgenstern

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

14

object named as

Markus Essler

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

Mario Vallon

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Birgit Blechert

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Zhoulei Li

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Klaus-Peter Gilbertz

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Anja Baumgart

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Michaela Aichler

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Annette Feuchtinger

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Florian C Gaertner

9

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Axel K Walch

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

8 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1886-1897

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Intraperitoneal radioimmunotherapy to treat the early phase of peritoneal dissemination of human colon cancer cells in a murine model

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Repeated Intraperitoneal alpha-Radioimmunotherapy of Ovarian Cancer in Mice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Targeted alpha therapy with 213Bi

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

(212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2203-Z

21 January 2018

Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol sensitizes human ovarian cancer cells to radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor endothelial marker 5 expression in endothelial cells during capillary morphogenesis is induced by the small GTPase Rac and mediates contact inhibition of cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actinium-225 in targeted alpha-particle therapeutic applications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of Ac-225 from Th-229 for targeted alpha therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylarsine oxide inhibition of endocytosis: effects on asialofetuin internalization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in cell cycle kinetics after ionizing irradiation below 1 GY

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22872310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-012-2203-Z

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39300912&oldid=2202760788"